Printer Friendly

Browse Crizotinib topic

Articles

1-43 out of 43 article(s)
Title Author Type Date Words
Global Soft Tissue Sarcoma (STS) Market Insights, Epidemiology, and Market Forecast 2019-2028. Dec 16, 2019 859
Japan,United States : Takeda Presents Long-Term Data in ALK+ NSCLC Showing ALUNBRIG (brigatinib) Continues to Demonstrate Superiority in the First-Line After Two Years of Follow-Up. Nov 25, 2019 213
Pfizer Inc. (NYSE: PFE). Oct 28, 2019 4348
Pfizer UK. Oct 22, 2019 4379
Pfizer Inc (NYSE: PFE). Oct 21, 2019 4348
Pfizer UK. Oct 15, 2019 4379
82025575-(ph No.:25115) Crizotinib 250 (crizalk 250 Mg) Cap. Accepted Description: Crizotinib 250 (crizalk 250 Mg) Cap. Brand: Crizalk 250 Mg. Mfd By M/s.pfizer Manufacturing Deutschland Gmbh/germany. Oct 15, 2019 101
Pfizer Inc (NYSE: PFE). Oct 14, 2019 4271
Pfizer Inc (NYSE: PFE). Oct 7, 2019 4271
Pfizer Inc (NYSE: PFE). Oct 1, 2019 4271
Pfizer UK. Sep 24, 2019 4379
Roche to present new data from its broad oncology portfolio at the European Society for Medical Oncology 2019 Congress. Sep 23, 2019 1237
Paperwork, High Costs Could Mean Worse Survival for Lung Cancer Patients. Norton, Amy Report Sep 3, 2019 722
82025575-(ph No.:25115) Crizotinib 250 (crizalk 250 Mg) Cap. Accepted Description: Crizotinib 250 (crizalk 250 Mg) Cap. Brand: Crizalk 250 Mg. Mfd By M/s.pfizer Manufacturing Deutschland Gmbh/germany. Jul 24, 2019 101
Tab Crizotinib 200mg And Tab Crizotinib 250mg. Jul 16, 2019 173
Combining breast, lung cancer drugs to treat cancer yields better results: study. Jul 12, 2019 489
Delivery Of The Medicinal Product Crizotinib. Jul 10, 2019 132
Brain Metastasis Mimicking Brain Abscess in ALK-Positive Non-Small-Cell Lung Cancer. Sakatani, Toshio; Kage, Hidenori; Takayanagi, Shunsaku; Watanabe, Kaoru; Hiraishi, Yoshihisa; Shinoz Jul 1, 2019 1449
Multiple Molecular Targets Associated with Genomic Instability in Lung Cancer. Soca-Chafre, Giovanny; Montiel-Davalos, Angelica; De La Rosa-Velazquez, Inti Alberto; Caro-Sanchez, Jul 1, 2019 5383
82025575-(ph No.:25115) Crizotinib 250 (crizalk 250 Mg) Cap. Accepted Description: Crizotinib 250 (crizalk 250 Mg) Cap. Brand: Crizalk 250 Mg. Mfd By M/s.pfizer Manufacturing Deutschland Gmbh/germany. Jun 12, 2019 101
New asthma jab and 'gene-silencing' drug approved in Scotland; Healthcare: Five new medicines accepted for use on the NHS. Jun 11, 2019 429
Japan : Takeda Presents Results from Lung Portfolio Including Phase 1/2 Study of TAK-788 in a Rare Form of NSCLC and New Data on Overall Health-Related Quality of Life for ALUNBRIG (brigatinib). Jun 6, 2019 890
Molecular Testing of Non-Small Cell Lung Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Fine-Needle Aspiration: The Cleveland Clinic Experience. Doxtader, Erika E.; Cheng, Yu-Wei; Zhang, Yaxia Jun 1, 2019 4154
Anticancer Screening of the Phytochemicals Present in the Medicinal Plant Vitex Negundo against Mutant Anaplastic lymphoma Kinase (ALK) Protein: A in-silico Approach. Anusha, D.; Sharanya, S.; Ramya; David, Darling Chellathai Jun 1, 2019 3363
Turning Point Therapeutics announces updated interim TRIDENT-1 data. Clinical report May 31, 2019 442
United States : European Commission Approves Lorviqua (Lorlatinib) for Certain Adult Patients With Previously-treated Alk-positive Advanced Non-small Cell Lung Cancer. May 11, 2019 567
The European Commission grants conditional marketing authorisation for Pfizer's LORVIQUA. May 10, 2019 196
The European Commission grants conditional marketing authorisation for Pfizer's LORVIQUA. May 10, 2019 192
European Commission Approves Lorviqua for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer. May 10, 2019 450
Pfizer says EC grants conditional marketing authorization for LORVIQUA. May 7, 2019 201
European Medicines Agency's committee recommends Pfizer's lung cancer drug. Mar 5, 2019 188
European Medicines Agency's committee recommends Pfizer's lung cancer drug. Mar 5, 2019 184
Pfizer Receives Positive CHMP Opinion for Lorviqua for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer. Mar 4, 2019 444
Pfizer receives positive opinion for LORVIQUA from CHMP. Mar 1, 2019 127
National lung cancer screening programme could save Kiwi lives. Mar 1, 2019 961
In NSCLC, Longer Survival With Brigatinib Than Crizotinib; Longer progression-free survival in those with ALK-positive dz who did not previously take ALK inhibitor. Oct 15, 2018 257
Anti-PD-1/PD-L1 Therapy for Non-Small-Cell Lung Cancer: Toward Personalized Medicine and Combination Strategies. Sui, Hongshu; Ma, Ningxia; Wang, Ying; Li, Hui; Liu, Xiaoming; Su, Yanping; Yang, Jiali Clinical report Jan 1, 2018 12468
Sclerotic Bone Metastasis in Pulmonary Adenocarcinoma. Hammamy, Riyadh Ali Mohammed; Farooqui, Khalid; Ghadban, Wisam Case study Jan 1, 2018 1720
Design, Synthesis, and Anticancer Activities of Novel 2-Amino-4-phenylthiazole Scaffold Containing Amide Moieties. Zhang, Zhi-Hua; Wu, Hong-Mei; Deng, Sai-Nan; Cai, Xiao-Yu; Yao, Yu; Mwenda, Muriira Cyrus; Wang, Jin Jan 1, 2018 7170
Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs. Fabrizio, F.P.; Sparaneo, A.; Trombetta, D.; Muscarella, L.A. Jan 1, 2018 13066
DNA Nanotweezers with Hydrolytic Activity for Enzyme-Free and Sensitive Detection of Fusion Gene via Logic Operation. Xu, Yongjie; Luo, Xiangrong; Geng, Nana; Wu, Mingsong; Lu, Zhishun Jan 1, 2018 4703
Resolution of Crizotinib-Associated Fulminant Hepatitis following Cessation of Treatment. Charville, Gregory W.; Padda, Sukhmani K.; Sibley, Richard K.; Puthillath, Ajithkumar; Kwo, Paul Y. Jan 1, 2018 2940
War on cancer. Moss, Ralph Dec 1, 2011 2436

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters